Neuroendocrine Cancer Management: CME Conference in New Mexico

11/04/2017

Neuroendocrine tumors (NETs) pose numerous clinical challenges due to their rarity, heterogeneity and lack of standardized diagnostic and therapeutic strategies. Over the last five years, the treatment landscape and biologic understanding of neuroendocrine tumors has shifted dramatically with significant advancements in diagnosis, loco-regional and systemic therapies rapidly being developed. Several large randomized phase III trials of novel treatments have resulted in new drug approvals and the increased knowledge of specific pathways implicated in neuroendocrine tumor growth has shifted the focus of many clinical trials.

In light of these exciting new developments, this conference, Neuroendocrine Cancer Management: Evolving Therapies and Approaches,  at the University of New Mexico Health Sciences Center has been customized to provide the latest evidence based practice to health care professionals.  Each session will address how the expanding treatment choices and research studies will influence individual treatment plans and impact NET patient management in the future.

Neuroendocrine cancer expert physicians Jonathan Strosberg, MD of the H. Lee Moffitt Cancer Center in Florida, and George A. Fisher, Jr., MD, PhD, of Stanford University Cancer Center in California, will be among the featured speakers.

Dr. Jonathan Strosberg and Dr. George A. Fisher

Dr. Jonathan Strosberg (left) and Dr. George A. Fisher (right)

Accreditation & Designation Statement:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the providership of the University of New Mexico Office of Continuing Medical Education.  The University of New Mexico Office of Continuing Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

The Office of Continuing Medical Education designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credit(s) TM.  Physicians should only claim the credit commensurate with the extent of their participation in the activity.

For additional information, please contact Continuing Medical Education & Professional Development at 505-272-3942 or CMEWeb@salud.unm.edu.

Click here for additional information.

Click here to download the brochure.

Register online by clicking here: https://secure.touchnet.com/C21597_ustores/web/product_detail.jsp?PRODUCTID=2003&SINGLESTORE=true

 

Print Friendly, PDF & Email

MORE INFO